Magle Chemoswed: Progressing as planned
Västra Hamnen Corporate Finance has released a research update on Magle Chemoswed following the company's report for Q1 2021. Revenues came in a little below our estimate but net profit still beat our expectation. The business is progressing well and will be further strengthened with the inclusion of PharmaCept later this year, writes Västra Hamnen.· Revenues lower but margins higher than expected · Acquisition of PharmaCept closed during the quarter · Revenues lower but margins higher than expected · Acquisition of PharmaCept closed during the quarter · We keep our valuation